David Dantzker is listed as an executive officer and director on 11 SEC Form D filings by 2 issuers between Mar 2012 and Dec 2024: Oligomerix, Inc. (White Plains, NY — pharmaceuticals — 2012–2024; $2.44M reported sold to 12 investors) and Origin Life Sciences, Inc. (Princeton, NJ — biotechnology — 2013–2023; $1.33M reported sold to 32 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $3.77M sold in total.
Listed alongside Victor Micati (7 shared filings), Michael David Preston (6 shared filings), Douglas Durand (5 shared filings), Jack Pasini (5 shared filings), James Moe (5 shared filings) and 17 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 11 public filings for David Dantzker and found 10 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.